SAB BIOTHERAPEUTICS, INC. Shares Outstanding
SAB BIOTHERAPEUTICS, INC. (SABS) had Shares Outstanding of 83.49 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Shares outstanding (split-adjusted) 83.49M shares; Shares authorized (split-adjusted) 800.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 75.74M shares; Shares authorized (split-adjusted) 800.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 47.61M shares; Shares authorized (split-adjusted) 800.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 47.49M shares; Shares authorized (split-adjusted) 800.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 83.49M shares 10-Q · filed 2026-08-06 | 800.00M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 75.74M shares 10-Q · filed 2026-05-12 | 800.00M shares 10-Q · filed 2026-05-12 |
| 2025-12-31 | 47.61M shares 10-Q · filed 2026-08-06 | 800.00M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 47.49M shares 10-Q · filed 2025-11-14 | 800.00M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 9.29M shares 10-Q · filed 2025-08-07 | 800.00M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 9.29M shares 10-Q · filed 2025-05-09 | 800.00M shares 10-Q · filed 2025-05-09 |
| 2024-12-31 | 9.29M shares 10-K · filed 2026-03-09 | 800.00M shares 10-K · filed 2026-03-09 |
| 2024-09-30 | 9.23M shares 10-Q · filed 2024-11-06 | 800.00M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 9.23M shares 10-Q · filed 2024-08-08 | 800.00M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 9.23M shares 10-Q · filed 2024-05-20 | 800.00M shares 10-Q · filed 2024-05-20 |
| 2023-12-31 | 9.23M shares 10-K · filed 2025-03-31 | 800.00M shares 10-K · filed 2025-03-31 |
| 2023-10-03 | (m) | 490.00M shares 10-K · filed 2024-03-29 |
| 2023-09-30 | 52.32M shares 10-Q · filed 2023-11-13 | 490.00M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 52.31M shares 10-Q · filed 2023-08-21 | 490.00M shares 10-Q · filed 2023-08-21 |
| 2023-03-31 | 50.40M shares 10-Q · filed 2023-05-15 | 490.00M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 5.04M shares 10-K · filed 2024-03-29 | 800.00M shares 10-K · filed 2024-03-29 |
| 2022-09-30 | 43.03M shares 10-Q · filed 2022-11-14 | 490.00M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 43.03M shares 10-K · filed 2023-04-14 | 490.00M shares 10-K · filed 2023-04-14 |
| 2022-03-31 | 42.96M shares 10-K · filed 2023-04-14 | 490.00M shares 10-K · filed 2023-04-14 |
| 2021-12-31 | 43.49M shares 10-K/A · filed 2023-04-28 | 490.00M shares 10-K/A · filed 2023-04-28 |
| 2021-09-30 | 3.29M shares 10-Q · filed 2021-11-22 | 50.00M shares 10-Q · filed 2021-11-22 |
| 2021-06-30 | 4.67M shares 10-Q · filed 2021-08-09 | 50.00M shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 4.46M shares 10-Q · filed 2021-05-21 | 50.00M shares 10-Q · filed 2021-05-21 |
| 2020-12-31 | 25.97M shares 10-K/A · filed 2023-04-28 | 490.00M shares 10-K/A · filed 2023-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |